NOMAD Power Solutions (NMAD) EGM 2026 summary
Event summary combining transcript, slides, and related documents.
EGM 2026 summary
30 Oct, 2026Opening remarks and agenda
Virtual special meeting called to order shortly after 1:00 p.m. ET; proceedings to follow the announced agenda and conduct rules.
Meeting notice was mailed on or about July 28, 2026, to eligible stockholders of record as of July 6, 2026.
Specific resolutions to be voted on
Proposal 1 implicated Nasdaq Listing Rules 5635(a) and 5635(b); Nasdaq required a new listing agreement to be filed and approved before the meeting.
Corporate governance
Jan W. Castillo was introduced as inspector of election; eligible stockholders and proxy holders could attend and vote online, with broker-issued legal proxies required for certain beneficial holders.
Partial view of Summaries dataset, powered by Quartr API
Latest events from NOMAD Power Solutions
- Public offering aims to fund cancer trials and restore Nasdaq compliance amid ongoing losses.NMAD
Registration filing - Biotech seeks $3.5M via unit offering to fund cancer trials amid Nasdaq compliance risks.NMADRegistration filing
- Net loss narrowed to $3.59M in 2024; urgent capital raise needed to sustain operations.NMADQ4 2024
- Net loss widened to $6.0 million in 2025; urgent capital needs persist amid ongoing clinical trials.NMADQ4 2025
- Biotech seeks up to $4M via unit offering to fund cancer trials and address Nasdaq compliance.NMADRegistration filing
- Net loss narrowed, cash runway extended, but clinical and funding risks remain significant.NMADQ2 2025
- Net loss narrowed, but continued operations depend on raising new capital by mid-2025.NMADQ1 2025
- Net loss narrowed, but urgent capital raise is needed to fund operations and maintain Nasdaq listing.NMADQ3 2024
- Biotech seeks capital via unit offering to fund cancer trials amid financial and Nasdaq risks.NMADRegistration filing